INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Pa...
PLYMOUTH MEETING, Pennsylvania, March 26, 2020 /PRNewswire-AsiaNet/ -- - VGX-3100 DNA medicine cleared high-risk HPV 16/18-associated precancerous lesions in 50% of patients, and reduced the number of lesions in 75% of patients- Data to be presented at the 2020 American Society for Colposcopy and Cervical Patholo...
Authors: LATEST ASIANET NEWS RELEASES